Design Therapeutics (DSGN) Market Cap

Price: $3.52
Market Cap: $199.80M
Avg Volume: 160.45K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.824
52W Range: $3.15-7.77
Website: Design Therapeutics

Market Cap Overview

Market Cap

$199.80M

Share Price

$3.52

Shares Outstanding

56.76M


What is Design Therapeutics's Market Cap?

Design Therapeutics's current Market Cap as of today is $199.80M.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Design Therapeutics, the market cap is calculated as $3.52 x 56.76M shares = $199.80M.

As a Micro Cap company, Design Therapeutics is a very small company that may be in its early stages.

Design Therapeutics Historical Market Cap

$2.00B$2.00B$1.60B$1.60B$1.20B$1.20B$800.00M$800.00M$400.00M$400.00M$0.00$0.00Market CapJul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Design Therapeutics Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Design Therapeutics, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$1.20B$1.20B$900.00M$900.00M$600.00M$600.00M$300.00M$300.00M$0.00$0.00ValueJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Design Therapeutics's enterprise value as of December 31, 2024 (Q4 2024) is calculated as:

  • Market Cap: $199.80M
  • Total Debt: $2.33M
  • Cash and Equivalents: $22.56M
  • Enterprise Value: $328.91M

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A higher enterprise value suggests significant debt levels.

Design Therapeutics Annual Market Cap History

Year Market Cap Change
2025 $199.80M -42.77%
2024 $349.14M 135.34%
2023 $148.36M -74.04%
2022 $571.56M -41.89%
2021 $983.58M -12.81%
2020 $1.13B 0.00%
2019 $1.13B N/A

Frequently Asked Questions

Design Therapeutics's current market capitalization is $199.80M. This makes it a Micro Cap company, calculated by multiplying its current stock price of $3.52 by 56.76M outstanding shares.

Design Therapeutics's enterprise value is $328.91M. This is calculated by adding total debt ($2.33M) to market cap and subtracting cash and equivalents ($22.56M). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Design Therapeutics has 56.76M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Design Therapeutics is classified as a Micro Cap company. Micro-cap companies are the smallest publicly traded companies with market caps below $300 million.

Design Therapeutics's market cap is calculated by multiplying its current stock price ($3.52) by its total number of outstanding shares (56.76M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for DSGN.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio